Attachment_1_-_OIG_Hotline_Poster.pdf

This notice describes a federal contract opportunity for medical countermeasures for pandemic influenza preparedness and response. The Biomedical Advanced Research and Development Authority within the Department of Health and Human Services intends to issue a Request for Proposal seeking cGMP influenza vaccine master and working seed lots, influenza vaccine research and investigational lots, cGMP influenza vaccine commercial scale bulk lots, cGMP adjuvant clinical or commercial scale bulk lots, formulation and filling services, storage and stability services, shipping, candidate vaccine viruses, potency reagents and standards manufacture and testing, analytical laboratory testing and assays, non-clinical and clinical studies, disposal of product, BARDA tracking tool development and testing of new standard data reporting formats, and additional reporting. The anticipated period of performance is three years base with two one-year option periods. Interested offerors should monitor the Federal Business Opportunities website for release of the RFP on or about January 12, 2015, with proposals due February 20, 2015 and estimated multiple awards by July 2015.